{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:35:21Z","timestamp":1787924121189,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P -36125"],"award-info":[{"award-number":["P -36125"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P -35871"],"award-info":[{"award-number":["P -35871"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P -36968"],"award-info":[{"award-number":["P -36968"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104981","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:07:33Z","timestamp":1783177653000},"page":"104981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b1-Synuclein regulates monoamine transporter capacity and amphetamine-induced efflux via modulation of transporter expression"],"prefix":"10.1016","volume":"393","author":[{"given":"Iina","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1631-2492","authenticated-orcid":false,"given":"Samuel","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lukenic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amila","family":"Sofic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2344-9753","authenticated-orcid":false,"given":"Samantha","family":"Kaltenbrunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"P\u00e4tzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hausleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Sucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9588-1389","authenticated-orcid":false,"given":"Marko","family":"Roblek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-4992","authenticated-orcid":false,"given":"Thomas","family":"Steinkellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6645","key":"10.1016\/j.jpet.2026.104981_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"5321","key":"10.1016\/j.jpet.2026.104981_bib2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jpet.2026.104981_bib3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/mds.29897","article-title":"Research priorities on the role of \u03b1-synuclein in Parkinson\u2019s disease pathogenesis","volume":"39","author":"Burr\u00e9","year":"2024","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.jpet.2026.104981_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.jpet.2026.104981_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s disease","volume":"150","author":"Sulzer","year":"2019","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.jpet.2026.104981_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.jpet.2026.104981_bib7","first-page":"916","article-title":"Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis","volume":"15","author":"Lee","year":"2001","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.jpet.2026.104981_bib8","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1111\/j.1460-9568.2006.05181.x","article-title":"Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein","volume":"24","author":"Wersinger","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104981_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1460-9568.2006.04900.x","article-title":"Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein","volume":"24","author":"Wersinger","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.jpet.2026.104981_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3940(03)00097-1","article-title":"Attenuation of dopamine transporter activity by alpha-synuclein","volume":"340","author":"Wersinger","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpet.2026.104981_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2011.01.064","article-title":"Decreased reuptake of dopamine in the dorsal striatum in the absence of \u03b1-synuclein","volume":"1382","author":"Chadchankar","year":"2011","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.jpet.2026.104981_bib12","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.1200575109","article-title":"Impaired neurotransmission caused by overexpression of \u03b1-synuclein in nigral dopamine neurons","volume":"109","author":"Lundblad","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"10.1016\/j.jpet.2026.104981_bib13","doi-asserted-by":"crossref","first-page":"43933","DOI":"10.1074\/jbc.M111.241232","article-title":"\u03b1-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter","volume":"286","author":"Swant","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2026.104981_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.658244","article-title":"Striatal dopamine transporter function is facilitated by converging biology of \u03b1-synuclein and cholesterol","volume":"15","author":"Threlfell","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jpet.2026.104981_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114959","article-title":"Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration","volume":"382","author":"Garcia Moreno","year":"2024","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpet.2026.104981_bib16","series-title":"Neurotransmitter Transporters: Investigative Methods","first-page":"1","article-title":"Classical radioligand uptake and binding methods in transporter research: an emphasis on the monoamine neurotransmitter transporters","author":"Sucic","year":"2016"},{"key":"10.1016\/j.jpet.2026.104981_bib17","series-title":"Neurotransmitter Transporters: Investigative Methods","first-page":"23","article-title":"Tracer flux measurements to study outward transport by monoamine neurotransmitter transporters","author":"Steinkellner","year":"2016"},{"issue":"8","key":"10.1016\/j.jpet.2026.104981_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023939","article-title":"Improved immunodetection of endogenous \u03b1-synuclein","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jpet.2026.104981_bib51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1523\/JNEUROSCI.17-04-01217.1997","article-title":"Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation","volume":"17","author":"Qi","year":"1997","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104981_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.104981_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0026-895X(25)08549-9","article-title":"Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter","volume":"47","author":"Pifl","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104981_bib21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neuropharm.2005.08.008","article-title":"Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines","volume":"49","author":"Hilber","year":"2005","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.jpet.2026.104981_bib22","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jpet.2026.104981_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jpet.2026.104981_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of cinpanemab in early Parkinson\u2019s disease","volume":"387","author":"Lang","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jpet.2026.104981_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2026.104981_bib26","first-page":"103","article-title":"The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d), methamphetamine and D-amphetamine","volume":"392","author":"Steinkellner","year":"2011","journal-title":"Biol Chem"},{"key":"10.1016\/j.jpet.2026.104981_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease","volume":"9","author":"Gigu\u00e8re","year":"2018","journal-title":"Front Neurol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104981_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tcb.2017.02.002","article-title":"\u03b1-Synuclein \u2013 regulator of exocytosis, endocytosis, or both?","volume":"27","author":"Lautenschl\u00e4ger","year":"2017","journal-title":"Trends Cell Biol"},{"issue":"8","key":"10.1016\/j.jpet.2026.104981_bib29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/genes12081166","article-title":"Roles for \u03b1-synuclein in gene expression","volume":"12","author":"Somayaji","year":"2021","journal-title":"Genes (Basel)"},{"issue":"6","key":"10.1016\/j.jpet.2026.104981_bib30","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200327","article-title":"Parkinson disease SNCA risk variants are associated with higher asymmetric putamen dopaminergic dysfunction","volume":"11","author":"Alhusaini","year":"2025","journal-title":"Neurol Genet"},{"issue":"11","key":"10.1016\/j.jpet.2026.104981_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026159","article-title":"SNCA triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate \u03b1-synuclein and are susceptible to oxidative stress","volume":"6","author":"Byers","year":"2011","journal-title":"PLoS One"},{"issue":"9440","key":"10.1016\/j.jpet.2026.104981_bib32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"5646","key":"10.1016\/j.jpet.2026.104981_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jpet.2026.104981_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41531-022-00379-8","article-title":"Linking the phenotype of SNCA triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding","volume":"8","author":"Wurster","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.jpet.2026.104981_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10571-007-9227-0","article-title":"Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells","volume":"28","author":"Guo","year":"2008","journal-title":"Cell Mol Neurobiol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104981_bib36","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/j.1460-9568.2008.06527.x","article-title":"The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons","volume":"28","author":"Fountaine","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"41","key":"10.1016\/j.jpet.2026.104981_bib37","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.1074\/jbc.M205518200","article-title":"Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line","volume":"277","author":"Lotharius","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.104981_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpet.2026.104981_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2014.10.016","article-title":"Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits","volume":"74","author":"Masoud","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"Pt 5","key":"10.1016\/j.jpet.2026.104981_bib40","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jpet.2026.104981_bib41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.nbd.2009.09.002","article-title":"Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson\u2019s disease","volume":"36","author":"Afonso-Oramas","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.jpet.2026.104981_bib42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.jpet.2026.104981_bib43","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1074\/jbc.M413887200","article-title":"Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta","volume":"280","author":"Johnson","year":"2005","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.jpet.2026.104981_bib44","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1523\/JNEUROSCI.4034-14.2015","article-title":"Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by \u03b1CaMKII","volume":"35","author":"Steinkellner","year":"2015","journal-title":"J Neurosci"},{"issue":"35","key":"10.1016\/j.jpet.2026.104981_bib45","doi-asserted-by":"crossref","first-page":"29627","DOI":"10.1074\/jbc.M112.367219","article-title":"Ca(2+)\/calmodulin-dependent protein kinase II\u03b1 (\u03b1CaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome","volume":"287","author":"Steinkellner","year":"2012","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jpet.2026.104981_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","article-title":"Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport","volume":"51","author":"Fog","year":"2006","journal-title":"Neuron"},{"issue":"49","key":"10.1016\/j.jpet.2026.104981_bib47","doi-asserted-by":"crossref","first-page":"29542","DOI":"10.1074\/jbc.M115.691592","article-title":"Dopamine transporter activity is modulated by \u03b1-synuclein","volume":"290","author":"Butler","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.104981_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","article-title":"Post-translational modifications of soluble \u03b1-synuclein regulate the amplification of pathological \u03b1-synuclein","volume":"26","author":"Zhang","year":"2023","journal-title":"Nat Neurosci"},{"issue":"24","key":"10.1016\/j.jpet.2026.104981_bib49","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","article-title":"Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function","volume":"111","author":"Parra-Rivas","year":"2023","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jpet.2026.104981_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","article-title":"Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity","volume":"9","author":"Ramalingam","year":"2023","journal-title":"NPJ Parkinsons Dis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652601181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652601181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:14:53Z","timestamp":1787922893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652601181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S002235652601181X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104981","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Synuclein regulates monoamine transporter capacity and amphetamine-induced efflux via modulation of transporter expression","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104981"}}